Jochen Brumm
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Surgery top 5%
- Lipoproteins and Cardiovascular Health
- Cholesterol and Lipid Metabolism
Papers in
-
- Protein purification and stability 3
- Bioinformatics and Genomic Networks 3
-
- Biosimilars and Bioanalytical Methods 5
- Co-authors
- Markus Abt (1 shared paper)Ingar Holme (1 shared paper)David Kallend (1 shared paper)Anders Olsson (1 shared paper)Hardi Mundl (1 shared paper)Prediman K. Shah (1 shared paper)R. Scott Wright (1 shared paper)Philip J. Barter (1 shared paper)
- Journals
- mAbs (3 papers)Bioanalysis (2 papers)PLoS ONE (2 papers)Canadian Journal of Diabetes (1 paper)Risk Analysis (1 paper)
- Partner nations
- United StatesCanadaSwitzerland
In The Last Decade
Jochen Brumm
25 papers receiving 2.1k citations
Jochen Brumm's Hit Papers
Peers
Comparison fields: 5 of 119
- Endocrinology, Diabetes and Metabolism 647
- Surgery 864
- Cancer Research 250
- Cardiology and Cardiovascular Medicine 280
- Health, Toxicology and Mutagenesis 140
Countries citing papers authored by Jochen Brumm
This map shows the geographic impact of Jochen Brumm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jochen Brumm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jochen Brumm more than expected).
Fields of papers citing papers by Jochen Brumm
This network shows the impact of papers produced by Jochen Brumm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jochen Brumm. The network helps show where Jochen Brumm may publish in the future.
Co-authors
The 25 scholars most cited alongside Jochen Brumm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome Hit paper breakdown → | 2012 | 1537 |
| 2 | 2008 | 151 | |
| 3 | 2017 | 108 | |
| 4 | 2001 | 103 | |
| 5 | 2019 | 80 | |
| 6 | 2002 | 40 | |
| 7 | 2021 | 32 | |
| 8 | 2008 | 25 | |
| 9 | 2021 | 24 | |
| 10 | 2005 | 22 | |
| 11 | 2021 | 17 | |
| 12 | 2022 | 11 | |
| 13 | 2018 | 11 | |
| 14 | 2022 | 10 | |
| 15 | 2008 | 10 | |
| 16 | 2024 | 9 | |
| 17 | 2020 | 7 | |
| 18 | 2019 | 7 | |
| 19 | 2016 | 4 | |
| 20 | 2024 | 2 |
About Jochen Brumm
Jochen Brumm is a scholar working on Molecular Biology, Immunology, Oncology, Physiology and Radiology, Nuclear Medicine and Imaging, having authored 29 papers that have together received 2.2k indexed citations. Recurring topics across this work include Biosimilars and Bioanalytical Methods (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Climate Change and Health Impacts (3 papers), Air Quality and Health Impacts (3 papers), CAR-T cell therapy research (3 papers), Cell Image Analysis Techniques (3 papers), Protein purification and stability (3 papers) and Bioinformatics and Genomic Networks (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (647 citations), Surgery (864 citations), Cancer Research (250 citations), Cardiology and Cardiovascular Medicine (280 citations) and Health, Toxicology and Mutagenesis (140 citations). Jochen Brumm has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Markus Abt, Ingar Holme, David Kallend, Anders Olsson, Hardi Mundl, Prediman K. Shah, R. Scott Wright, Philip J. Barter, Stephen J. Nicholls and Jean‐Claude Tardif. Their work appears in journals such as mAbs, Bioanalysis, PLoS ONE, Canadian Journal of Diabetes and Risk Analysis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.